Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 4,073 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Hepatocellular Carcinoma
Interventions: TheraBionic Device, Placebo Device; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Chicago, Illinois • New York, New York • Winston-Salem, North Carolina

Conditions: Suicidal Thoughts and Behaviors, Social Connectedness, Responses to Social Threat
Interventions: Social threat; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 12 Years to 17 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Vaginal Infection, Vaginal Discharge, Vaginosis, Sexual Dysfunction
Interventions: LiviWell Postcoital Vaginal Insert; Device
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Mountain Lakes, New Jersey

Conditions: Chronic Pancreatitis
Interventions: Pancreatic fully-covered self-expanding metal stent (FCSEMS); Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 6
States / cities: Aurora, Colorado • Indianapolis, Indiana • Pittsburgh, Pennsylvania + 3 more

Conditions: Leukemia, Myeloid, Monocytic
Interventions: BSMA; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Eye Disorders, Cataract Extraction, Cataract and IOL Surgery, Cataract Surgery Experience, Cataract Surgery, Intraocular Lens
Interventions: LLM-based Education; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Oropharyngeal Cancer, Neck Cancer, Human Papillomavirus, HPV, Anal Cancer, Cervical Cancer, Penile Cancer, Vulvar Cancer, Vaginal Cancer, Colon Cancer
Interventions: Bintrafusp Alfa, PDS01ADC, Entinostat; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Knee Osteoarthritis
Interventions: Implementation Strategy: Foundational REP, Implementation Strategy: Enhanced REP (enREP); Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Substance Use
Interventions: Pink Cloud, Active Control; Behavioral
Lead sponsor: Loyola Marymount University; Other
Eligibility: 18 Years and older
Enrollment: 1,410 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia
Interventions: Exercise, Calls and Newsletter; Behavioral · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Years and older · Male only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Borderline Personality Disorder, Self-Injurious Behavior
Interventions: N-Acetylcysteine, placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Autism Spectrum Disorder
Interventions: N-acetylcysteine, Placebo; Drug
Lead sponsor: Emory University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Sleep Apnea, Obstructive, Continuous Positive Airway Pressure
Interventions: MET, ED; Behavioral
Lead sponsor: National Jewish Health; Other
Eligibility: 30 Years to 80 Years
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Chronic Pain, Pain, Widespread Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury
Interventions: Pain Ed, CBT for Pain, Usual Care; Behavioral · Other
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 19 Years and older
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Tuscaloosa, Alabama • Greenville, North Carolina

Conditions: Diabetes Mellitus, Type 2
Interventions: Brief CBT; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 30 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Health Promotion
Interventions: Functional Medicine Health Coaching for Elimination Diet for Elimination Diet, Self-guided Elimination Diet; Behavioral
Lead sponsor: The Institute for Functional Medicine; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Federal Way, Washington

Conditions: Mild Traumatic Brain Injury (mTBI)
Interventions: Symptom-Targeted Approach to Rehabilitation for Concussion; Behavioral
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Wahiawa, Hawaii • San Antonio, Texas

Conditions: IUD, Contraception
Interventions: IUD self-removal guide; Other
Lead sponsor: University of Washington; Other
Eligibility: 14 Years and older · Female only
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Renton, Washington

Conditions: Birth Control, Contraception
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 4,430 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Sarcoma,Soft Tissue
Interventions: Tirzepatide; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 39 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Burnout
Interventions: Emotional Wellbeing, EHR Skills Optimization, Performance Improvement, control; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: Not listed
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anxiety
Interventions: FW-200; Device
Lead sponsor: Fisher Wallace Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia • Seattle, Washington

Conditions: Type 2 Diabetes
Interventions: Statin, PCSK9 inhibitor, Ezetimibe 10mg; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 89 Years
Enrollment: 151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer, Tobacco Dependence
Interventions: placebo, varenicline; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma

Social Threat, Adolescent Relationships, and Suicidality Study

Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters

WallFlex Pancreatic Metal Stent for Pancreatic Duct Strictures

Physical Activity as Self-Management Approach to Improve Health Outcomes in AML

Effectiveness of a Large Language Model-Based Educational Tool on Intraocular Lens Options

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

Implementing Group Physical Therapy (PT) for Veterans With Knee Osteoarthritis (Group PT): Function QUERI 2.0

An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

PRescription Exercise for Older Men With Urinary Disease

N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD

A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder

Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study)

Literacy-Adapted Psychosocial Treatments for Chronic Pain --- "Learning About Mastering/My Pain"

Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study

Functional Medicine Health Coaching

Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C)

IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings

HER Salt Lake Initiative

PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study

Keck Medicine of University of Southern California Thrive Study

A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders

CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)